With reference to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, whereunder the listed entities are required to submit the ‘Initial Disclosure’, if falling within the criteria mentioned in point no. 2.2 of the above-mentioned circular for determining ‘Large Corporate’. In this context, Sharda Ispat Pharma has informed that the Company does not fall under Large Corporate category for the financial year ended 31st March, 2026 as per the framework mentioned in the aforesaid circular.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sharda Ispat | 163.60 |
| MFS Intercorp | 17.29 |
| Indu Engg. & Textile | |
| Astra Metal Systems | |
| Duplex Industries | |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: